Pharma Industry News Weekly Recap: September 1, 2023
// Biotech and Pharma Therapeutics BMS publishes 'modest' multiple myeloma survival data on heir to Revlimid, Pomalyst August 30, [...]
// Biotech and Pharma Therapeutics BMS publishes 'modest' multiple myeloma survival data on heir to Revlimid, Pomalyst August 30, [...]
// Biotech and Pharma Therapeutics Moderna reveals Claudin18.2 ambitions via cancer vaccine, solid tumor CAR-T combo plans August [...]
// Biotech and Pharma Therapeutics Clearmind Medicine Collaboration with CTS Ltd., a Leading Pharmaceutical/Consumer Products Company August 14, 2023 [...]
// Biotech and Pharma Therapeutics Lilly's Innovative Approach in the Pursuit of Pain Relief June 5, 2023 / [...]
// Biotech and Pharma Therapeutics Atea rejects takeover bid from Concentra May 30, 2023 / Atea / Concentra [...]
// Biotech and Pharma Therapeutics Bayer's blockbuster hopeful Nubeqa, AstraZeneca's Forxiga pick up nods from England's NICE May [...]
// Biotech and Pharma Therapeutics Bayer Receives U.S. FDA Fast Track Designation for asundexian Atrial Fibrillation Program May [...]
// Biotech and Pharma Therapeutics Boehringer Ingelheim to surf with Melbourne-based biotech in $181M neuropsychiatric therapy deal May [...]
// Biotech and Pharma Therapeutics Astellas keeps the big buyouts rolling, inking $5.9B Iveric takeover ahead of FDA [...]
// Biotech and Pharma Therapeutics 'Lots of ways for donanemab to win' in Alzheimer's, Lilly says. Now, it just [...]